PARIS — German consumer goods company Beiersdorf AG’s 2021 organic sales rose 9.7 percent to 7.63 billion euros, outpacing pre-pandemic levels of 2019.

In reported terms, the Hamburg, Germany-based maker of Nivea products’ sales increased 8.6 percent, spurred by its Tesa, La Prairie and Derma businesses.

Implied organic sales growth within the fourth quarter was around 2.6 percent, in keeping with Bernstein.

“Beiersdorf seems to have had an OK end of the yr in organic growth…in step with consensus, but corporations reporting till now had material beats on organic growth,” wrote Bernstein analyst Bruno Monteyne in a note Tuesday.

For the yr, Beiersdorf’s consolidated EBIT margin was up 10 basis points to 13 percent.

The corporate’s Tesa Business Segment, producer of adhesives, posted organic growth of 13.6 percent to 1.5 billion euros.

Sales on the Consumer Business Segment were organically up 8.8 percent to six.13 billion euros, driven by the selective cosmetics segment. Beiersdorf said demand for La Prairie climbed 20.1 percent, on account of the recovery of travel retail. The Derma business, including the Eucerin and Aquaphor brands, continued performing strongly, up 19.5 percent, especially within the U.S., Germany, Latin America and China.

Nivea, considered Beiersdorf’s core brand, recorded 5.5 organic sales growth in 2021.

Jefferies analyst Molly Wylenzek wrote in a note that Nivea was sequentially weaker within the fourth quarter and below expectations. “The turnaround of Nivea is becoming an increasingly urgent priority,” she wrote.

For 2022, Beiersdorf expects its sales overall, and for the Consumer and Tesa Business Segments, to achieve within the mid-single-digit range. The group’s consolidated EBIT margin ought to be about on a par with 2021’s.

“The group expects the development within the skincare market to proceed in 2022,” Beiersdorf said in an announcement.

FOR MORE, SEE:

Beiersdorf Is Investing in a Digital Derm Appointments Start-up

Beiersdorf to Acquire Chantecaille

Beiersdorf Returns to Pre-pandemic Sales Level in First Half

Beiersdorf Names Latest Head of Pharmacy and Selective Division